サマリー

SDMO(Contract DEevelopment and Manufacturing Organization)とは、医薬品業界にサービスを提供する組織で、医薬品の開発から製造までの包括的なサービスを顧客に提供します。

市場分析と洞察。医薬品CDMOサービスの世界市場
医薬品CDMOサービスの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のPharmaceutical CDMO Services市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には世界の医薬品CDMOサービス市場全体の規模（売上高）も含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のPharmaceutical CDMO Services市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のPharmaceutical CDMO Services市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の医薬品CDMOサービスの範囲と市場規模
医薬品CDMOサービス市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のPharmaceutical CDMO Services市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
医薬品物質の開発および製造
専門サービス
ラボベースのサービス

アプリケーション別セグメント
革新的医薬品
特許薬
特許切れの医薬品

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
Recipharm AB
AMRIグローバル
パテオンN.V.
アエノバ・グループ
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
ストライド・ファーマ・サイエンス社
ピラマル・ファーマ・ソリューションズ
ジークフリート社
ファレバグループ
FAMARヘルスケアサービス

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Substance Development and Manufacturing
1.2.3 Specialized Services
1.2.4 Lab-based Services
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Innovative Medicine
1.3.3 Patented Drug
1.3.4 Patent Expired Drug
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Services Market Perspective (2016-2027)
2.2 Pharmaceutical CDMO Services Growth Trends by Regions
2.2.1 Pharmaceutical CDMO Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical CDMO Services Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical CDMO Services Industry Dynamic
2.3.1 Pharmaceutical CDMO Services Market Trends
2.3.2 Pharmaceutical CDMO Services Market Drivers
2.3.3 Pharmaceutical CDMO Services Market Challenges
2.3.4 Pharmaceutical CDMO Services Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue
3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2020
3.5 Pharmaceutical CDMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CDMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CDMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2022-2027)

5 Pharmaceutical CDMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmaceutical CDMO Services Market Size (2016-2027)
6.2 North America Pharmaceutical CDMO Services Market Size by Type
6.2.1 North America Pharmaceutical CDMO Services Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical CDMO Services Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical CDMO Services Market Size by Type (2016-2027)
6.3 North America Pharmaceutical CDMO Services Market Size by Application
6.3.1 North America Pharmaceutical CDMO Services Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical CDMO Services Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical CDMO Services Market Size by Application (2016-2027)
6.4 North America Pharmaceutical CDMO Services Market Size by Country
6.4.1 North America Pharmaceutical CDMO Services Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical CDMO Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pharmaceutical CDMO Services Market Size (2016-2027)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type
7.2.1 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical CDMO Services Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application
7.3.1 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical CDMO Services Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical CDMO Services Market Size by Country
7.4.1 Europe Pharmaceutical CDMO Services Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical CDMO Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO Services Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmaceutical CDMO Services Market Size (2016-2027)
9.2 Latin America Pharmaceutical CDMO Services Market Size by Type
9.2.1 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical CDMO Services Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical CDMO Services Market Size by Application
9.3.1 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical CDMO Services Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical CDMO Services Market Size by Country
9.4.1 Latin America Pharmaceutical CDMO Services Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical CDMO Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO Services Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Details
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.1.5 Recipharm AB Recent Development
11.2 AMRI Global
11.2.1 AMRI Global Company Details
11.2.2 AMRI Global Business Overview
11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.2.5 AMRI Global Recent Development
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Details
11.3.2 Patheon N.V. Business Overview
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.3.5 Patheon N.V. Recent Development
11.4 Aenova Group
11.4.1 Aenova Group Company Details
11.4.2 Aenova Group Business Overview
11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.4.5 Aenova Group Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.5.5 Catalent, Inc. Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.6.5 Amatsigroup Recent Development
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Details
11.7.2 WuXi AppTec Group Business Overview
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.7.5 WuXi AppTec Group Recent Development
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Details
11.8.2 Strides Pharma Science Limited Business Overview
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.8.5 Strides Pharma Science Limited Recent Development
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Details
11.9.2 Piramal Pharma Solutions Business Overview
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.9.5 Piramal Pharma Solutions Recent Development
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Details
11.10.2 Siegfried Ltd Business Overview
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.10.5 Siegfried Ltd Recent Development
11.11 Fareva Group
11.11.1 Fareva Group Company Details
11.11.2 Fareva Group Business Overview
11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.11.5 Fareva Group Recent Development
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Details
11.12.2 FAMAR Health Care Services Business Overview
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.12.5 FAMAR Health Care Services Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details